These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26116754)

  • 1. PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.
    Lv XB; Liu CY; Wang Z; Sun YP; Xiong Y; Lei QY; Guan KL
    EMBO Rep; 2015 Aug; 16(8):975-85. PubMed ID: 26116754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat stress activates YAP/TAZ to induce the heat shock transcriptome.
    Luo M; Meng Z; Moroishi T; Lin KC; Shen G; Mo F; Shao B; Wei X; Zhang P; Wei Y; Guan KL
    Nat Cell Biol; 2020 Dec; 22(12):1447-1459. PubMed ID: 33199845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
    Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
    Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
    Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
    Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the Hippo-YAP pathway by protease-activated receptors (PARs).
    Mo JS; Yu FX; Gong R; Brown JH; Guan KL
    Genes Dev; 2012 Oct; 26(19):2138-43. PubMed ID: 22972936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation.
    Matsushita A; Sato T; Mukai S; Fujishita T; Mishiro-Sato E; Okuda M; Aoki M; Hasegawa Y; Sekido Y
    Oncogene; 2019 Mar; 38(11):1966-1978. PubMed ID: 30401981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo signaling is intrinsically regulated during cell cycle progression by APC/C
    Kim W; Cho YS; Wang X; Park O; Ma X; Kim H; Gan W; Jho EH; Cha B; Jeung YJ; Zhang L; Gao B; Wei W; Jiang J; Chung KS; Yang Y
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9423-9432. PubMed ID: 31000600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.
    Liu CY; Lv X; Li T; Xu Y; Zhou X; Zhao S; Xiong Y; Lei QY; Guan KL
    J Biol Chem; 2011 Feb; 286(7):5558-66. PubMed ID: 21189257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
    Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
    J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brahma regulates the Hippo pathway activity through forming complex with Yki-Sd and regulating the transcription of Crumbs.
    Zhu Y; Li D; Wang Y; Pei C; Liu S; Zhang L; Yuan Z; Zhang P
    Cell Signal; 2015 Mar; 27(3):606-13. PubMed ID: 25496831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
    Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
    Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.
    Wu LMN; Deng Y; Wang J; Zhao C; Wang J; Rao R; Xu L; Zhou W; Choi K; Rizvi TA; Remke M; Rubin JB; Johnson RL; Carroll TJ; Stemmer-Rachamimov AO; Wu J; Zheng Y; Xin M; Ratner N; Lu QR
    Cancer Cell; 2018 Feb; 33(2):292-308.e7. PubMed ID: 29438698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.
    Liu CY; Zha ZY; Zhou X; Zhang H; Huang W; Zhao D; Li T; Chan SW; Lim CJ; Hong W; Zhao S; Xiong Y; Lei QY; Guan KL
    J Biol Chem; 2010 Nov; 285(48):37159-69. PubMed ID: 20858893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
    Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
    J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
    Zhao B; Lei QY; Guan KL
    Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.
    Dai X; She P; Chi F; Feng Y; Liu H; Jin D; Zhao Y; Guo X; Jiang D; Guan KL; Zhong TP; Zhao B
    J Biol Chem; 2013 Nov; 288(47):34041-34051. PubMed ID: 24106267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.
    Lei QY; Zhang H; Zhao B; Zha ZY; Bai F; Pei XH; Zhao S; Xiong Y; Guan KL
    Mol Cell Biol; 2008 Apr; 28(7):2426-36. PubMed ID: 18227151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type-dependent function of LATS1/2 in cancer cell growth.
    Pan WW; Moroishi T; Koo JH; Guan KL
    Oncogene; 2019 Apr; 38(14):2595-2610. PubMed ID: 30531839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells.
    Heidary Arash E; Shiban A; Song S; Attisano L
    EMBO Rep; 2017 Mar; 18(3):420-436. PubMed ID: 28183853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.